Patheon Development and Manufacturing Capabilities Highlighted at Global Summit

A prominent expert from Patheon, a leading global provider of high-quality drug development and delivery solutions to the pharmaceutical and biopharma sectors, will highlight the company’s strategy for delivering exceptional customer experience through its broad set of integrated offerings at the Seventh Annual Global Biomanufacturing Summit.

Dr. Laura Parks, senior vice president of corporate operations and strategic initiatives, will showcase drug development and manufacturing services available from Patheon, Wednesday, Feb. 18, at 4:05 p.m., in stream 1 at the Hyatt Regency hotel in Orange County, Calif. Building on more than 20 years of life science industry experience, Parks will present “Evolution of Drug Development and Manufacturing Services,” underscoring the company’s early adoption of integrated solutions, driving the pharma industry’s transition to more simplified development and manufacturing processes, while also exploring evolutions outside of the biopharmaceutical spectrum.

For more information or to request a digital copy of Parks’ presentation, please visit http://www.patheon.com/Knowledge-Library/Events/Event-Detail.aspx?eid=198&tab=1.

Patheon Media Relations

Tel: +1 (919) 210-0986

Email:  tyler.gronbach@patheon.com or media@patheon.com

Patheon, a business unit of DPx Holdings B.V., delivers a combination of unrivaled quality, reliability and compliance, with a reputation for scientific and technical excellence to customers in the pharmaceutical and biopharma sector. A leading global provider with more than 8,000 employees worldwide, Patheon has a comprehensive set of solutions to help customers of all sizes satisfy complex development and manufacturing needs at any stage of the pharmaceutical development cycle. For more information, visit http://www.patheon.com.